Helyx Industries SpAMIL:HLX -0.28%61 Days Payable is 319.14 as of Dec. 2025, which is 46% below its 10-year median of 586.95. GuruFocus rates MIL:HLX with a GF Score™ of 61/100 and a GF Value™ of €3.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, Helyx Industries SpA ranks better than 80.77% on this metric.
The historical rank and industry rank for Helyx Industries SpA's Days Payable or its related term are showing as below:
MIL:HLX'
s Days Payable Range Over the Past 10 Years
Min: 244.26 Med: 586.95 Max: 883.41
Current: 563.47
During the past 8 years, Helyx Industries SpA's highest Days Payable was 883.41. The lowest was 244.26. And the median was 586.95.
MIL:HLX's Days Payable is ranked better than 80.77% of 702
companies
in the Biotechnology industry
Industry Median: 113.56
vs MIL:HLX: 563.47
Helyx Industries SpA's Days Payable
declined
from Dec. 2024 (746.72) to Dec. 2025 (319.14).
It may suggest that Helyx Industries SpAaccelerated paying its suppliers.
Helyx Industries SpA Days Payable Related Terms
Helyx Industries SpA Days Payable Historical Data
* Premium members only.
The historical data trend for Helyx Industries SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:HLX vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Helyx Industries SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helyx Industries SpA Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Helyx Industries SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Helyx Industries SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Helyx Industries SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helyx Industries SpA (MIL:HLX) has a Days Payable of 319.14 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Helyx Industries SpA and its competitors. This is 46% below median its historical median of 586.95. Over the past decade, Helyx Industries SpA's Days Payable has ranged from 244.26 to 883.41. According to the industry distribution chart, Helyx Industries SpA ranks #135 out of 702 companies in the Biotechnology industry, placing it in the top 19.2%.
Is Helyx Industries SpA's Days Payable too high?
Helyx Industries SpA's current Days Payable of 319.14 is 46% below median its 10-year median of 586.95. Over the past 10 years, this metric has ranged from a low of 244.26 to a high of 883.41. The Biotechnology industry median Days Payable is 113.56. Helyx Industries SpA's value of 319.14 is 181% above this industry median. Based on the distribution chart, Helyx Industries SpA ranks #135 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Helyx Industries SpA has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Helyx Industries SpA's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helyx Industries SpA ranks #135 out of 702 companies for Days Payable. This places Helyx Industries SpA in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Helyx Industries SpA's value of 319.14 is 181% above this benchmark. Historically, Helyx Industries SpA's own Days Payable has ranged from 244.26 to 883.41 over the past decade. While the company's 10-year median is 586.95 vs. the industry median of 113.56, Helyx Industries SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Helyx Industries SpA's current Days Payable of 319.14 is 181% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Helyx Industries SpA and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Helyx Industries SpA's current Days Payable is 319.14, which is 46% below median its own 10-year median of 586.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helyx Industries SpA stock overvalued right now?
Based on GuruFocus' analysis, Helyx Industries SpA (MIL:HLX) is currently considered Possible Value Trap. The stock's GF Value™ is €3.45, compared to a current price of €0.72 — trading 79.2% below its estimated fair value. The current Days Payable is 319.14, which is 46% below median its 10-year median of 586.95 and 181% above the Biotechnology industry median of 113.56. Helyx Industries SpA's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Helyx Industries SpA (MIL:HLX), the current Days Payable is 319.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Helyx Industries SpA (MIL:HLX) Overvalued in 2026?
Based on GuruFocus' analysis, Helyx Industries SpA stock appears to be undervalued.
The current stock price of €0.72 is trading 79.2% below its estimated GF Value™ of €3.45.
GuruFocus considers Helyx Industries SpA to be Possible Value Trap.
Key valuation signals for MIL:HLX:
Days Payable: 319.14 (46% below median its 10-year median of 586.95)
GF Value™: €3.45 vs. price of €0.72 (79.2% below fair value)
Industry Position: 181% above the Biotechnology median (#135 of 702)
No single metric tells the full story. See the MIL:HLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Helyx Industries SpA is a healthcare biotech company focusing on genetics. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions.
61GF Score
Get the complete analysis for MIL:HLX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HLX has been successfully added to your 
